We are live on ! Find out more
KXA

KPCB XIV Associates Portfolio holdings

AUM $42.8M
1-Year Est. Return 16.52%
This Fund
S&P 500
This Quarter Est. Return
-46.73%
1 Year Est. Return
-16.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$267M
AUM Growth
Cap. Flow
+$324M
Cap. Flow %
121.39%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Staples 96.96%
2 Healthcare 3.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BYND icon
1
Beyond Meat
BYND
$277M
$259M 96.96%
+3,419,321
New +$317M
OYST
2
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$8.09M 3.04%
+367,987
New +$6.46M

Similar funds

KPCB XIV Associates's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for KPCB XIV Associates, which disclosed 2 positions worth $267M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Beyond Meat: 3,419,321 shares worth $259M.

By sector, the portfolio is most concentrated in Consumer Staples at 97% of assets, followed by Healthcare.

  • KPCB XIV Associates's largest Q4 2019 buy was Beyond Meat: 3,419,321 shares worth $259M.
  • KPCB XIV Associates's ten largest holdings make up 100% of its $267M portfolio in Q4 2019.
  • KPCB XIV Associates disclosed 2 positions in Q4 2019, its first 13F filing on record.

Based on KPCB XIV Associates's 13F filing for Q4 2019, filed 13 Feb 2020.